中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Menu
Volume 35 Issue 2
Feb.  2019
Turn off MathJax
Article Contents
Abstract
References
Article Navigation >  Journal of Clinical Hepatology  > 2019  >  35(2): 334-337

Value of FibroScan combined with gamma-glutamyl transpeptidase-to-platelet ratio in predicting liver fibrosis in patients with chronic hepatitis B:A preliminary study

DOI: 10.3969/j.issn.1001-5256.2019.02.018

  • Department of Gastroenterology, Guangzhou Eighth People′s Hospital

Research funding:

 

  • Published Date: 2019-02-20
    Abstract

  • Objective To investigate the value of FibroScan combined with gamma-glutamyl transpeptidase-to-platelet ratio ( GPR) in predicting liver fibrosis stage in patients with chronic hepatitis B ( CHB) . Methods A total of 278 patients who were diagnosed with CHB by liver biopsy in Guangzhou Eighth People's Hospital from January 2012 to December 2016 were enrolled. The value of GPR and FibroScan used alone or in combination in predicting liver fibrosis stage ( F0-F4) was analyzed. The Kruskal-Wallis H test was used for comparison of non-normally distributed continuous data between multiple groups and the Mann-Whitney U test was used for further comparison between two groups. The Spearman's correlation coefficient was used for correlation analysis. The area under the receiver operating characteristic curve ( AUC) was used to evaluate liver fibrosis stage. Results With liver biopsy as the gold standard, of all patients, 50 had stage F1 fibrosis, 104 had stage F2 fibrosis, 92 had stage F3 fibrosis, and 32 had stage F4 fibrosis. Liver stiffness measurement by FibroScan gradually increased with the increase in liver fibrosis stage ( P < 0. 05) , and GPR also increased gradually in patients with stage F1, F2, and F3 liver fibrosis ( P < 0. 05) . GPR and FibroScan were positively correlated with liver fibrosis ( r = 0. 419 and 0. 481, both P < 0. 001) , and GPR was positively correlated with FibroScan ( r = 0. 436, P < 0. 001) . According to AUC, FibroScan combined with GPR had a better diagnostic efficiency than FibroScan ( 0. 793 vs 0. 739, Z = 3. 044, P = 0. 002) or GPR ( 0. 793 vs 0. 740, Z = 2. 389, P = 0. 037) alone in predicting progressive liver fibrosis ( ≥F3) ; FibroScan combined with GPR had a better diagnostic efficiency than GPR alone ( 0. 782 vs0. 714, Z = 2. 130, P = 0. 033) in predicting marked liver fibrosis ( ≥F2) . Conclusion FibroScan combined with GPR has a certain advantage in predicting progressive liver fibrosis ( ≥F3) in CHB patients and can improve diagnostic efficiency.

     

    • FullText(HTML)
    • References(17)
  • [1]XU X, SU Y, SONG R, et al.Performance of transient elastography assessing fibrosis of single hepatitis B virus infection:Asystematic review and meta-analysis of a diagnostic test[J].Hepatol Int, 2015, 9 (4) :558-566.
    [2]LI Y, HUANG YS, WANG ZZ, et al.Systematic review with meta-analysis:The diagnostic accuracy of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B[J].Aliment Pharmacol Ther, 2016, 43 (4) :458-469.
    [3]ZENG X, XU C, HE D, et al.Performance of several simple, noninvasive models for assessing significant liver fibrosis in patients with chronic hepatitis B[J].Croat Med J, 2015, 56 (3) :272-279.
    [4]TANG QR, HE Q, TANG QY.Research advances in non-invasive diagnosis models for liver fibrosis in chronic hepatitis B[J].JClin Hepatol, 2015, 31 (8) :1355-1359. (in Chinese) 唐情容, 何清, 唐奇远.慢性乙型肝炎肝纤维化无创性诊断模型的研究进展[J].临床肝胆病杂志, 2015, 31 (8) :1355-1359.
    [5]Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B:A 2015 update[J].JClin Hepatol, 2015, 31 (12) :1941-1960. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2015年更新版) [J].临床肝胆病杂志, 2015, 31 (12) :1941-1960.
    [6]DONG JJ, GUO HH.Association betweenγ-glutamyl transpeptidase-to-platelet ratio and hepatic fibrosis in patients with chronic hepatitis B[J].J Clin Hepatol, 2017, 33 (3) :548-552. (in Chinese) 董菁菁, 郭宏华.GGT与PLT比值指数对慢性乙型肝炎肝纤维化的诊断价值[J].临床肝胆病杂志, 2017, 33 (3) :548-552.
    [7]LEMOINE M, SHIMAKAWA Y, NAYAGAM S, et al.The gammaglutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa[J].Gut, 2016, 65 (8) :1369-1376.
    [8]WANG RQ, ZHANG QS, ZHAO SX, et al.Gamma-glutamyl transpeptidase to platelet ratio index is a good noninvasive biomarker for predicting liver fibrosis in Chinese chronic hepatitis B patients[J].J Int Med Res, 2016, 44 (6) :1302-1313.
    [9]HU YC, LIU H, LIU XY, et al.Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B[J].World J Gastroenterol, 2017, 23 (41) :7425-7432.
    [10]LI Y, CAI Q, ZHANG Y, et al.Development of algorithms based on serum markers and transient elastography for detecting significant fibrosis and cirrhosis in chronic hepatitis B patients:Significant reduction in liver biopsy[J].Hepatol Res, 2016, 46 (13) :1367-1379.
    [11]TERRAULT NA, LOK ASF, McMAHON BJ, et al.Update on prevention, diagnosis, and treatment of chronic hepatitis B:AASLD 2018 hepatitis B guidance[J].Hepatology, 2018, 67 (4) :1560-1599.
    [12]Expert Committee on Clinical Application of Transient Elastography.Expert consensus on chinical application of transient elastography (TE) (2015) [J/CD].Chin J Liver Dis:Electronic Edition, 2015, 7 (2) :12-18. (in Chinese) 瞬时弹性成像技术临床应用共识专家委员会.瞬时弹性成像技术 (TE) 临床应用专家共识 (2015年) [J/CD].中国肝脏病杂志:电子版, 2015, 7 (2) :12-18.
    [13]JIN CT, GUO LW, LIANG WF.Research progress on non-invasive serum markers for liver fibrosis assessment in patients with chronic hepatitis B[J/CD].Chin J Exp Clin Infect Dis:E-lectronic Edition, 2018, 12 (1) :11-14. (in Chinese) 金彩婷, 郭利伟, 梁伟峰.慢性乙型病毒性肝炎肝纤维化无创性血清诊断指标研究进展[J/CD].中华实验和临床感染病杂志:电子版, 2018, 12 (1) :11-14.
    [14]LEE J, KIM MY, KANG SH, et al.The gamma-glutamyl transferase to platelet ratio and the FIB-4 score are noninvasive markers to determine the severity of liver fibrosis in chronic hepatitis B infection[J].Br J Biomed Sci, 2018, 75 (3) :128-132.
    [15]LIU DP, LU W, ZHANG ZQ, et al.Comparative evaluation of GPR versus APRI and FIB-4 in predicting different levels of liver fibrosis of chronic hepatitis B[J].J Viral Hepat, 2018, 25 (5) :581-589.
    [16]HUANG CM, YANG Z, NIE YQ, et al.Value of gamma-glutamyl transpeptidase-to-platelet ratio in predicting liver fibrosis stage in chronic hepatitis B patients in Guangdong, China[J].J Clin Hepatol, 2018, 34 (6) :1204-1208. (in Chinese) 黄春明, 杨湛, 聂玉强, 等.GGT/PLT比值对广东地区慢性乙型肝炎患者肝纤维化分期的预测价值[J].临床肝胆病杂志, 2018, 34 (6) :1204-1208.
    [17]ZHAO W, ZHANG SY, LU Y, et al.FibroTouch combined with FIB-4, APRI and GPRI in diagnosis of liver fibrosis[J].Clin Focus, 2018, 33 (2) :140-144. (in Chinese) 赵文, 张思雨, 路宇, 等.FibroTouch联合FIB-4、APRI及GPRI评估肝纤维化[J].临床荟萃, 2018, 33 (2) :140-144.
    • Relative Articles

  • Relative Articles

    [1]Guodong SHI, Zipeng LU, Kuirong JIANG. Diagnosis and treatment of dyspepsia associated with pancreatic tumors[J]. Journal of Clinical Hepatology, 2023, 39(12): 2770-2774. doi: 10.3969/j.issn.1001-5256.2023.12.004
    [2]Min LIU, Weijian CHEN, Zhengzhen ZHOU, Xiaomei QIN, Rong WEN, Nan JIANG, Linzhi KUANG, Taiqing ZHENG, Liqiong ZHANG, Shuangjie LI. Histopathological characteristics of the liver in children with non-alcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2023, 39(5): 1144-1149. doi: 10.3969/j.issn.1001-5256.2023.05.021
    [3]Li WANG, Yongfeng YANG. Diagnosis and treatment of autoimmune hepatitis: The indispensable role of pathology[J]. Journal of Clinical Hepatology, 2023, 39(3): 504-510. doi: 10.3969/j.issn.1001-5256.2023.03.004
    [4]Qian ZHAO, Yongliang FENG, Yan WANG, Zhigang WEI. Clinical characteristics of patients with pancreatic cancer combined with new onset diabetes mellitus[J]. Journal of Clinical Hepatology, 2022, 38(12): 2780-2786. doi: 10.3969/j.issn.1001-5256.2022.12.018
    [5]Yuanjiao GAO, Yanjie LIN, Liu YANG, Xiaoyue BI, Wen DENG, Tingting JIANG, Fangfang SUN, Yao LU, Lu ZHANG, Minghui LI, Yao XIE. Liver histopathology and clinical features of autoimmune hepatitis with different antibody statuses[J]. Journal of Clinical Hepatology, 2022, 38(12): 2744-2749. doi: 10.3969/j.issn.1001-5256.2022.12.012
    [6]Tingting BI, Sihui HOU, Yan LIU. Expression of neural precursor cell expressed developmentally downregulated 4-1 in pancreatic cancer tissue and its clinical significance[J]. Journal of Clinical Hepatology, 2022, 38(3): 617-621. doi: 10.3969/j.issn.1001-5256.2022.03.024
    [7]Bai XiaoMei, Sun RunQin, Chen XiaoLi. Clinical and pathological features of solid pseudopapillary neoplasm of the pancreas: An analysis of 14 cases[J]. Journal of Clinical Hepatology, 2019, 35(5): 1047-1051. doi: 10.3969/j.issn.1001-5256.2019.05.022
    [8]Jiang LiLin, Shen JianBo, Tang Hong, Lu ZhongHua. Pathological differential diagnosis of inflammatory liver injury[J]. Journal of Clinical Hepatology, 2018, 34(11): 2278-2282. doi: 10.3969/j.issn.1001-5256.2018.11.003
    [9]Zheng SuLi, Zhang TaiPing. An excerpt of laparoscopic surgery for pancreatic neoplasms: the European Association for Endoscopic Surgery clinical consensus conference（2017）[J]. Journal of Clinical Hepatology, 2017, 33(5): 816-819. doi: 10.3969/j.issn.1001-5256.2017.05.004
    [10]Chen Jie. Pathological and differential diagnoses of exocrine pancreatic tumors[J]. Journal of Clinical Hepatology, 2013, 29(1): 45-49.
    [11]Zhang WenYing, Jin ZhenDong. Endoscopic ultrasound -guided treatment for pancreatic tumor[J]. Journal of Clinical Hepatology, 2012, 28(8): 573-575+578.
    [13]Yang XiaoJing, Yang ZhuLin, Huang JiangSheng, Yang LePing, Fu Xi. Study on pathological significance in the expression of the nerve growth factor (NCF) and its mRNA in benign and malignant lesions of gallbladder.[J]. Journal of Clinical Hepatology, 2008, 24(3): 207-209.
    [14]Zhang RongGui, Tang ZhengHao, Feng Jie, Zang GuoQing, Yu YongSheng. The expression of c-myb in HCC tissues and clinical significance.[J]. Journal of Clinical Hepatology, 2008, 24(2): 106-108.
    [15]Yang LePing, Yang ZhuLin, Lan SiGen, Fu Xi, Huang JiangSheng, Luo Xin. Expression of insulin-like growth factor-binding protein-2 (IGFBP2) and matrix metalloproteinase-9 (MMP9) and its clinicopathologieal significances in benign and malignant lesions of gallbladder[J]. Journal of Clinical Hepatology, 2008, 24(6): 442-445.
    [16]Shan HaiXia, Wu AiHua, Hou JinLin, Zhu YouFu. Clinical and pathological characteristics of autoimmune liver disease.[J]. Journal of Clinical Hepatology, 2008, 24(2): 111-113.
    [17]Gu HuaPing, Liu YanRu, Shang PeiZhong. Expression of CD44v6 and C-erbB-2 in gallbladder neoplasms and their relatonship[J]. Journal of Clinical Hepatology, 2002, 18(6): 370-371.
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (2013) PDF downloads(318) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[2151]YesterdayPV[4214]TodayIP[65]TodayPV[92]Online[34]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return